The reproductive health therapy developer, which has raised more than $93m from backers including Novo and Merck Group, has set the terms for its initial public offering.

Tencent, which led a $90m series C round in 2015, has returned to lead a $55m series D round that also attracted Alphabet and new investor Recruit.

The cloud software provider has reportedly invested nearly $10m in a total of five startups, including Zentron Labs and VTitan.

Pain management drug developer SiteOne Therapeutics has secured Amgen as a research and development partner and lead investor in its series B round.

The online lender's wealth management subsidiary has reached the first close of its second venture capital fund to be focused on Israel, and is targeting $50m for the final close.

Takeda has taken part in a series B round for therapeutic antibody developer Maverick Therapeutics as part of a collaboration deal sized at up to $125m in total.

Radiotherapy and diagnostic imaging services provider Concord Medical has joined forces with investment firm ZRT for a strategic healthcare fund.